Time to incident hypertension and independent predictors among people living with HIV in Nigeria.

Autor: Ajayi OA; APIN Public Health Initiatives, Plot 1551, Zone E, Apo Resettlement, Apo, Abuja, Nigeria., Okonkwo P; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria., Ojo TO; Department of Community Health, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria., Ajayi OK; Community Medicine Department, University College Hospital, Ibadan, Nigeria., Ogunsola O; Prevention and Community Services, APIN Public Health Initiatives, Ibadan Office, Nigeria., Osayi E; Clinical Services, APIN Public Health Initiatives, Plateau Office, Nigeria., Onwuatuelo I; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria., Samuels JO; Program Department, APIN Public Health Initiatives, Headquarter Office, Abuja, Nigeria.

Publikováno v: Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2024 Oct 18; Vol. 11, pp. 20499361241289800. Date of Electronic Publication: 2024 Oct 18 (Print Publication: 2024).

FERNANDO AND THE THAMES BARGE.

Publikováno v: Kirkus Reviews. 2/15/2019, Vol. 87 Issue 4, pN.PAG-N.PAG. 1p.

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Autor: Ogbenna AA; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Meloni S; Department of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Inzaule S; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands., Hamers RL; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.; Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Sigaloff K; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Amsterdam, Netherlands., Osibogun A; Department of Community Health and Primary Care, College of Medicine, Faculty of Clinical Sciences, University of Lagos, Lagos, Nigeria., Adeyemo TA; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Okonkwo P; APIN Public Health Initiatives Ltd/Gte, Abuja, Nigeria., Samuels JO; APIN Public Health Initiatives Ltd/Gte, Abuja, Nigeria., Kanki PJ; Department of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Rinke de Wit TF; Department of Global Health, Amsterdam UMC, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands., Akanmu AS; Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.

Publikováno v: PloS one [PLoS One] 2020 Aug 25; Vol. 15 (8), pp. e0238027. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).

Association between HIV-1 subtype and drug resistance in Nigerian infants.

Autor: Chaplin B; Department of Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Akanmu AS; Department of Haematology and Blood Transfusion, College of Medicine of the University of Lagos, Lagos, Nigeria., Inzaule SC; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Samuels JO; APIN Public Health Initiatives, Ltd/Gte, Abuja, Nigeria., Okonkwo P; APIN Public Health Initiatives, Ltd/Gte, Abuja, Nigeria., Ilesanmi O; World Health Organization, Abuja, Nigeria., Adewole IFA; Department of Obstetrics and Gynaecology, University of Ibadan, and the Federal Ministry of Health, Abuja, Nigeria., Asadu C; Federal Ministry of Health, Abuja, Nigeria., Khamofu H; FHI 360, Abuja, Nigeria., Mpazanje R; World Health Organization, Abuja, Nigeria., Ndembi N; Institute of Human Virology in Nigeria, Abuja, Nigeria., Odafe S; Centers for Disease Control and Prevention, Abuja, Nigeria., Sigaloff KCE; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Ngige EN; Federal Ministry of Health, Abuja, Nigeria., Abatta EO; Federal Ministry of Health, Abuja, Nigeria., Akinbiyi G; Federal Ministry of Health, Abuja, Nigeria., Dakum P; Institute of Human Virology in Nigeria, Abuja, Nigeria., Rinke de Wit TF; Amsterdam Institute for Global Health and Development & Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands., Kanki P; Department of Immunology & Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Jan 01; Vol. 74 (1), pp. 172-176.

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.

Autor: Akanbi, Maxwell. O.^1,2,3,4 (AUTHOR) Maxwell_akanbi@yahoo.com, Bilaver, Lucy. A.² (AUTHOR), Achenbach, Chad² (AUTHOR), Hirschhorn, Lisa. R.² (AUTHOR), Rivera, Adovich. S.² (AUTHOR), Adekolujo, Orimisan. S.³ (AUTHOR), Adekola, Kehinde. U. A.² (AUTHOR), Silas, Olugbenga. A.⁴ (AUTHOR), Agaba, Patricia. A.⁴ (AUTHOR), Agbaji, Oche⁴ (AUTHOR), Shehu, Nathan. Y.⁴ (AUTHOR), Sagay, Solomon. A.⁴ (AUTHOR), Hou, Lifang² (AUTHOR), Murphy, Robert. L.² (AUTHOR)

Publikováno v: BMC Cancer. 9/21/2023, Vol. 23 Issue 1, p1-9. 9p.